Canada markets open in 6 hours 31 minutes

IM Cannabis Corp. (IMCC)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
5.24-0.19 (-3.50%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close5.43
Open5.26
Bid0.00 x 1300
Ask0.00 x 1000
Day's Range4.88 - 5.39
52 Week Range0.49 - 11.63
Volume248,223
Avg. Volume50,567
Market Cap254.841M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • ACCESSWIRE

    IM Cannabis Announces Pricing of Proposed Public Offering of Securities

    TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / May 5, 2021 / IM Cannabis Corp. ("IMC" or the "Company") (CSE:IMCC) (NASDAQ:IMCC), a multi-country operator ("MCO") in the medical and adult-use recreational cannabis sector with operations in Israel, Germany and Canada, announces that is has entered into a best-efforts agency agreement (the "Agency Agreement") in connection with its previously announced overnight marketed offering (the "Offering") of common shares of the Company (each an "Offered Share") and common shares purchase warrants (each a "Warrant").

  • ACCESSWIRE

    IM Cannabis Announces Proposed Public Offering of Securities

    TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / May 4, 2021 / IM Cannabis Corp. ("IMC" or the "Company") (CSE:IMCC)(NASDAQ:IMCC), a multi-country operator ("MCO") in the medical and adult-use recreational cannabis sector with operations in Israel, Germany and Canada, announces that it has commenced an overnight marketed offering (the "Offering") of the Company's common shares (each an "Offered Share") on a best-efforts agency basis.

  • ACCESSWIRE

    IM Cannabis Acquires Israel's Largest Retail and Online Pharmacy Business from Panaxia, Creating a Vertically Integrated Global Platform for the IMC Brand

    ("IMC" or the "Company") (CSE:IMCC)(NASDAQ:IMCC), a multi-country operator ("MCO") in the medical and adult-use recreational cannabis sectors with operations in Israel, Germany and Canada, announced today that its fully owned Israeli subsidiary, IMC Holdings Ltd., along with Panaxia Pharmaceutical Industries Israel Ltd.